Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Abacus Life Inc. (ABL:NASDAQ), powered by AI.
Abacus Life Inc. is currently trading at $8.30. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Abacus Life Inc. on Alpha Lenz.
Abacus Life Inc.'s P/E ratio is -24.5.
“Abacus Life Inc. trades at a P/E of -24.5 (undervalued) with modest ROE of -8.1%. 3Y revenue CAGR of 70.5% highlights clear growth momentum.”
Ask for details →Abacus Life Inc. is an industry-leading company specializing in life settlement solutions and services. Its primary focus is on purchasing and managing life insurance policies, offering individuals the opportunity to sell their policies for immediate cash. This offers policyholders a viable financial planning tool, particularly for seniors who may no longer need or afford their insurance coverage. Abacus Life Inc. plays a significant role in the financial market by providing liquidity and flexibility to policyholders, impacting sectors like estate planning, retirement financing, and wealth management. The company's operations touch various industries, including insurance, finance, and consumer services, making it a key player in the intersection of personal finance and insurance services. Established with a mission of enhancing financial independence for policyholders, Abacus Life Inc. leverages its expertise to provide personalized solutions, ensuring transparency and value for clients. This positions Abacus as an important entity in the evolving landscape of life settlements, advocating for consumer choices and financial innovation.
“Abacus Life Inc. trades at a P/E of -24.5 (undervalued) with modest ROE of -8.1%. 3Y revenue CAGR of 70.5% highlights clear growth momentum.”
Ask for details →Abacus Life Inc. (ticker: ABL) is a company listed on NASDAQ in the Financial Services sector (Insurance - Life). It has approximately 157 employees. Market cap is $587M.
The current price is $8.3 with a P/E ratio of -24.51x and P/B of 1.38x.
ROE is -8.15% and operating margin is 1.65%. Annual revenue is $112M.